This protocol is judged by an institutional overview board, an unbiased team that testimonials any scientific trials involving individuals. If a review will involve a Timetable I drug, after the board approves the protocol as ethical, the scientists have to make an application for an investigational new drug (IND) number with the FDA.Drugs can also